Biovitrum Ab

Markus Thor

Benjamin Pelcman

Erik Ringberg

Björn M Nilsson

Jan Tejbrant

Jonas Nilsson

Gary Johansson

Ulf J Bremberg

Patrizia Caldirola

Annika Jenmalm Jensen

Andrew Mott

Mattias Jönsson

Katarina Beierlien

Lars Tedenborg

Magnus Cernerud

Bj&ouml;rn M Nilsson

Helena Lundström

Mattias J&ouml;nsson

The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system. 

Substituted naphthalene sulfonamides

The invention relates to compounds of the general formula (I): wherein The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder, such as eating disorders, especially obesity, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctions, and urinary disorders The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of formula (I).

Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases

Compounds of the general formula (I):  Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the treatment of 5-HTreceptor-related disorders or medical conditions.

Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones

The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system 

Bicyclic sulfonamide compounds

The invention relates to compounds of the general formula (I):wherein The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder, such as eating disorders, especially obesity, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctions, and urinary disorders. The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of formula (I).

Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases

Growing community of inventors

Knivsta, Sweden

Markus Thor